Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lijun Mu

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cancer Immunology Research|June 1, 2016
Antitumor Efficacy of Radiation plus Immunotherapy Depends upon Dendritic Cell Activation of Effector CD8+ T CellsSimon J Dovedi, Grazyna Lipowska-Bhalla, Stephen A Beers, et al.
Pharmaceutics|January 25, 2025
Preparation of pH-Responsive Tanshinone IIA-Loaded Calcium Alginate Nanoparticles and Their Anticancer MechanismsTianying Ren, Jing Wang, Yingxin Ma, et al.
Oncology Reports|September 9, 2020
MicroRNA‑218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2Lijun Mu, Bing Guan, Juanhua Tian, et al.
Pharmaceutics|March 28, 2026
Correction: Ren et al. Preparation of pH-Responsive Tanshinone IIA-Loaded Calcium Alginate Nanoparticles and Their Anticancer Mechanisms. <i>Pharmaceutics</i> 2025, <i>17</i>, 66Tianying Ren, Jing Wang, Yingxin Ma, et al.
Oncology Reports|September 14, 2022
[Corrigendum] MicroRNA‑218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2Lijun Mu, Bing Guan, Juanhua Tian, et al.
Journal of Experimental Botany|March 18, 2022
PHB3 regulates lateral root primordia formation via NO-mediated degradation of AUXIN/INDOLE-3-ACETIC ACID proteinsShuna Li, Qingqing Li, Xiao Tian, et al.
Oncotarget|December 29, 2016
Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancerBing Guan, Kaijie Wu, Jin Zeng, et al.
Oncotarget|March 14, 2022
Correction: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancerBing Guan, Kaijie Wu, Jin Zeng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 21, 2026
The Maize ZmbHLH118 Transcription Factor Regulates Vacuolar Nitrate Loading by the NO<sub>3</sub> <sup>-</sup> Transporter ZmCLCaChaonan Zhang, Elsa Demes-Causse, Xujian Li, et al.
Science Advances|January 28, 2022
A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel diseaseChengxin Shi, Jianati Dawulieti, Feiyu Shi, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancer Immunology Research|June 1, 2016
Antitumor Efficacy of Radiation plus Immunotherapy Depends upon Dendritic Cell Activation of Effector CD8+ T CellsSimon J Dovedi, Grazyna Lipowska-Bhalla, Stephen A Beers, et al.
Pharmaceutics|January 25, 2025
Preparation of pH-Responsive Tanshinone IIA-Loaded Calcium Alginate Nanoparticles and Their Anticancer MechanismsTianying Ren, Jing Wang, Yingxin Ma, et al.
Oncology Reports|September 9, 2020
MicroRNA‑218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2Lijun Mu, Bing Guan, Juanhua Tian, et al.
Pharmaceutics|March 28, 2026
Correction: Ren et al. Preparation of pH-Responsive Tanshinone IIA-Loaded Calcium Alginate Nanoparticles and Their Anticancer Mechanisms. <i>Pharmaceutics</i> 2025, <i>17</i>, 66Tianying Ren, Jing Wang, Yingxin Ma, et al.
Oncology Reports|September 14, 2022
[Corrigendum] MicroRNA‑218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2Lijun Mu, Bing Guan, Juanhua Tian, et al.
Journal of Experimental Botany|March 18, 2022
PHB3 regulates lateral root primordia formation via NO-mediated degradation of AUXIN/INDOLE-3-ACETIC ACID proteinsShuna Li, Qingqing Li, Xiao Tian, et al.
Oncotarget|December 29, 2016
Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancerBing Guan, Kaijie Wu, Jin Zeng, et al.
Oncotarget|March 14, 2022
Correction: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancerBing Guan, Kaijie Wu, Jin Zeng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 21, 2026
The Maize ZmbHLH118 Transcription Factor Regulates Vacuolar Nitrate Loading by the NO<sub>3</sub> <sup>-</sup> Transporter ZmCLCaChaonan Zhang, Elsa Demes-Causse, Xujian Li, et al.
Science Advances|January 28, 2022
A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel diseaseChengxin Shi, Jianati Dawulieti, Feiyu Shi, et al.
Pageof 3